Hypothesis

Age‑related loss of neuronal METTL3/14 initiates a top‑down signal that remodels the intestinal microenvironment through vagal efferents and HIF‑1α stabilization in gut epithelium, thereby selecting for a dysbiotic microbiome that further suppresses neuronal m6A writers. Restoring neuronal m6A breaks this loop and re‑establishes eubiosis.

Mechanistic Rationale

• Germ‑free mice show upregulated brain METTL3, METTL14, ALKBH5 and FTO compared with colonized controls, indicating that the microbiome normally tones down neuronal m6A activity [[https://pmc.ncbi.nlm.nih.gov/articles/PMC11834532/]].
• Neuronal METTL14 loss destabilizes Atp2a3 mRNA, impairing ER calcium handling and triggering chronic UPR [[https://bioengineer.org/mettl14-loss-in-neurons-impairs-er-triggers-parkinsons/]].
• METTL3 knock‑down in aged olfactory neurons reduces m6A by ~33 % and compromises mitochondrial metabolism [[https://pmc.ncbi.nlm.nih.gov/articles/PMC12957708/]].
• High‑fat‑diet induced dysbiosis lowers intestinal METTL3/14 and the phenotype is transmissible by fecal transplant [[https://pmc.ncbi.nlm.nih.gov/articles/PMC11834532/]], proving that microbial composition can regulate methyltransferase expression.

We propose that ER stress and mitochondrial dysfunction in aging neurons increase vesicular release of specific miRNAs (e.g., miR‑124‑3p) and activate vagal efferents. Vagal signaling raises epithelial HIF‑1α stability, which shifts the luminal oxygen gradient toward anaerobiosis, favoring pathobionts (e.g., Enterobacteriaceae) and depleting obligate anaerobes that produce butyrate. The resulting metabolite deficit (lower butyrate, higher LPS) feeds back to the brain via vagal afferents and circulation, further inhibiting neuronal METTL3/14 through HDAC activation and inflammatory signaling—creating a self‑amplifying gut‑brain loop.

Experimental Design

1. Neuronal METTL3/14 knockdown: Use AAV‑Cre in METTL3^fl/fl; METTL14^fl/fl mice targeting excitatory forebrain neurons at 12 months of age. Include a control AAV‑GFP group.
2. Vagal interrogation: Sub‑diaphragmatic vagotomy or chemogenetic inhibition (hM4Di) in a subset of knockdown mice to test necessity of the vagal arm.
3. Readouts (4 weeks post‑surgery):
   • Fecal 16S rRNA sequencing for community structure.
   • Cecal SCFA quantification (GC‑MS).
   • Gut epithelial HIF‑1α protein (Western blot, immunohistochemistry).
   • Neuronal m6A levels (MeRIP‑seq) and METTL3/14 expression.
   • Behavior: rotarod, grip strength, and cognitive maze performance.
4. Rescue experiment: In another cohort, co‑inject AAV‑Syn‑METTL3 (wild‑type) with the knockdown construct to assess whether restoring neuronal m6A normalizes HIF‑1α, microbiome, and functional outcomes.
5. Transmissibility test: Transfer feces from knockdown mice to germ‑free recipients; assess whether recipients develop HIF‑1α elevation and dysbiosis without neuronal manipulation.

Expected Outcomes

• Neuronal METTL3/14 loss will increase epithelial HIF‑1α, shift microbiota toward facultative anaerobes, reduce butyrate, and elevate LPS.
• Vagotomy or chemogenetic inhibition will block these gut changes, confirming the efferent vagal route.
• Restoring neuronal METTL3 will reverse HIF‑1α activation, re‑establish butyrate‑producing taxa, and improve motor/cognitive performance.
• Fecal transplant from knockdown mice will recapitulate HIF‑1α elevation and dysbiosis in germ‑free hosts, proving sufficiency of the microbiome signal.

Potential Limitations

Compensatory changes in other m6A writers or demethylases could mask effects; measuring global m6A dynamics will help. Vagal manipulation may affect gut motility independently of HIF‑1α; including motility assays will control for this confound. Finally, mouse findings may not fully translate to human aging kinetics, but the mechanistic axis (neuronal stress → vagal/HIF‑1α → mucosal oxygen → microbiome) is conserved and can be probed in organ‑on‑chip models.